Antioxidants and cardiovascular disease

Current Opinion in Investigational Drugs

Volumn 6, Issue 9, 2005, Pages 895-900

  Violi, Francesco ^a   Cangemi, Roberto ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Antioxidant; Atherosclerosis; Cardiovascular disease; Oxidative stress; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; DIETARY INTAKE; DISEASE COURSE; DRUG EFFICACY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK REDUCTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; HUMANS; HYPERCHOLESTEROLEMIA; OXIDATIVE STRESS; RISK FACTORS; VITAMIN E;

EID: 24644524607     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Steinberg D, Witzium JL: Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation (2002) 105(17):2107-2111.
2. Violi F, Micheletta F, Iuliano L: How to select patient candidates for antioxidant treatment? Circulation (2002) 106(24): e195.
3. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med (1999) 340(2):115-126.
4. Pearson TA: New tools for coronary risk assessment: What are their advantages and limitations? Circulation (2002) 105(7):886-892.
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 74(6):1141-1148.
6. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A: Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation (1998) 97(22):2222-2229.
7. Mezzetti A, Cipollone F, Cuccurullo F: Oxidative stress and cardiovascular complications in diabetes: Isoprostanes; as new markers on an old paradigm. Cardiovasc Res (2000) 47(3):475-488.
8. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with Insulin-dependent diabetes mellitus. J Am Coll Cardiol (1998) 31(3):552-557.
9. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation (1997) 96(1):25-28.
10. Wolin MS: Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol (2000) 20(6):1430-1442.
11. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NADPH oxidase and endothelial nitric oxide synthase. Circulation (2002) 105(14):1656-1662.
12. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG: Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation (1995) 92(4):898-903.
13. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol (1997) 17(11):3230-3235.
14. Sanguigni V, Pignatelli P, Caccese D, Pulcinelli FM, Lenti L, Magnaterra R, Martini F, Lauro R, Violi F: Increased superoxide anion production by platelets in hypercholesterolemic patients. Thromb Haemost (2002) 87(5):796-801.
15. Takemoto M, Liao JK: Pleiotropic effects of 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol (2001) 21(11):1712-1719.
16. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F: Simvastatin inhibits the monocyte expression of proinflammatory, cytokines in patients with hypercholesterolemia. J Am Coll Cardiol (2000) 36(2):427-431.
17. 2-isoprostane formation in hypercholesterolemic subjects: No further effect of vitamin E. Circulation (2002) 106(20):2543-2549.
18. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 332(18):1198-1203.
19. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 328(20):1444-1449.
20. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett C: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 328(20):1450-1456.
21. Gey KF, Puska P, Jordan P, Moser UK: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr (1991) 53(1 Suppl):326S-334S.
22. Singh RB, Ghosh S, Niaz MA, Singh R, Beegum R, Chibo H, Shoumin Z, Postiglione A: Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol (1995) 76(17):1233-1238.
23. Mezzetti A, Zuliani G, Romano F, Costantini F, Pierdomenico SD, Cuccurullo F, Fellin R: Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people. J Am Geriatr Soc (2001) 49(5):533-537.
24. Iannuzzi A, Celentano E, Panico S, Galasso R, Covetti G, Sacchetti L, Zarrilli F, De Michele M, Rubba P: Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women. Am J Clin Nutr (2002) 76(3):582-587.
25. Iuliano L, Micheletta F, Maranghi M, Frati G, Diczfalusy U, Violi F: Bioavailability of vitamin E as function of food intake in healthy subjects: Effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol (2001) 21(10):E34-E37.
26. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT: Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland. Br Med J (1997) 314(7081):634-638.
27. Vita JA, Keeney JF Jr, Raby KE, Morrow JD, Freedman JE, Lynch S, Koulouris SN, Hankin BR, Frei B: Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol (1998) 31(5):980-986.
28. Gale CR, Marlyn CN, Winter PD, Cooper C: Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J (1995) 310(6994):1563-1566.
29. Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka T, Sivenius J, Salonen JT: Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke (2002) 33(6):1568-1573.
30. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M: Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation (2002) 105(10):1155-1157.
31. Sinclair AJ, Taylor PB, Lunsc J, Girling AJ, Barnett AH: Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med (1994) 11(9):893-898.
32. Weisburger JH: Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr (1991) 53(1):226S-237S.
33. Padayatty SJ, Levine M: Vitamin C and myocardial infarction: The heart of the matter. Am J Clin Nutr (2000) 71(5):1027-1028.
34. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S: The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med (1995) 123(11):860-872.
35. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Itallano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet (1999) 354(9177):447-455.
36. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 342(3):154-160.
37. de Gaetano G: Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet (2001) 357(9250):89-95.
38. Carroll MF, Schade DS: Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation (2003) 108(1):24-31.
39. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP: Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 349(9067):1715-1720.
40. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet (1996) 347(9004):781-786.
41. Boaz M, Smetana S, Weinstein T, Mates Z, Gafter U, Iaina A, Knecht A, Welssgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet (2000) 356(9237):1213-1218.
42. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet (2002) 360(9326):23-33.
43. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P: Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet (2002) 359(9312):1108-1113.
44. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation (2003) 107(7):947-953.
45. Pryor WA: Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med (2000) 28(1):141-164.
46. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ: Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet (2003) 361(9374):2017-2023.
47. Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA: Effects of vitamin E on lipid peroxidation in healthy persons. J Am Med Assoc (2001) 285(9):1178-1182.